Back

SGLT2 inhibitors in patients with diabetes and ischemic heart disease

3 November 2023 (17:10 - 17:35)
Organised by: Logo
Seminar Presentation Part of: The new era of SGLT2 Inhibitors in Cardiovascular Disease: beyond glucose control Cardiovascular Pharmacotherapy Open Access EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy WG on Cardiovascular Pharmacotherapy

About the speaker

Photo
Associate Professor Edoardo Mannucci

(Italy)

2 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors across the spectrum of heart failure
Professor M. Metra (Milan, IT)
Presentation thumbnail
Discussion

Access the full session

Session thumbnail
The new era of SGLT2 Inhibitors in Cardiovascular Disease: beyond glucose control

The Event

Event poster

EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

3 November 2023 17:10 CET
You may be interested in
thumbnail
Congress Presentation
Sodium-glucose co-transporter-2 inhibitors improve cardiovascular outcomes in heart failure with reduced ejection fraction regardless of ischemic etiology
27 August 2021
thumbnail
Congress Presentation
The gender gap in prescription pattern of Sodium-Glucose Cotransporter 2 inhibitors in patients with Type 2 Diabetes and Coronary Artery Disease
28 August 2023
thumbnail
Congress Session
The power of now: a focus on SGLT2 inhibitors for heart failure in the hospital
17 May 2025
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources